Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C

Hepatology Research

Volumn 33, Issue 4, 2005, Pages 269-271

  Nakamura, Hideji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; CHRONIC HEPATITIS; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; EDITORIAL; ERADICATION THERAPY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; TREATMENT PLANNING; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

EID: 29144492204     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.09.038     Document Type: Editorial

References (19)

1. H.S. Conjeevaram J.E. Everhart J.H. Hoofnagle Prediction of a sustained beneficial response to interferon alpha therapy in chronic hepatitis C Hepatology 22 1995 1326-1329
2. N. Enomoto I. Sakuma Y. Asahina et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C genotype 1b infection N Engl J Med 334 1996 77-81
3. G.L. Davis J.Y.N. Lau Factors predictive of a beneficial response to therapy of hepatitis C Hepatology 26 1997 122S-127S
4. A.U. Neuman N.P. Lam H. Dahari et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy Science 282 1998 103-107
5. Y. Asahina N. Izumi M. Uchihara et al. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta Hepatology 34 2001 377-384
6. S. Zeuzem E. Herrmann J.-H. Lee et al. Viral kinetics in patients with chronic hepatitis C treated wiyth standard or peginterferon α2a Gastroenterology 120 2001 1438-1447
7. S. Zeuzem J.M. Schmidt J.-H. Lee M. von Wagner G. Teuber W.K. Roth Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover Hepatology 28 1998 245-252
8. P. Ferenci Predictors of response to therapy for chronic hepatitis C Semin Liv Dis 24 Suppl. 2 2004 25-31
9. M.-P. Civeira J. Prieto Early prediction of response to treatment in patients with chronic hepatitis C J Hepatol 31 Suppl. 1 1999 237-243
10. S. Iino E. Tomita H. Kumada et al. Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: Relationship of baseline viral levels and viral dynamics during and after therapy Hepatol Res 30 2004 63-70
11. J.G. McHutchison J.A. Shad S.C. Gordon et al. Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy J Viral Hepatitis 8 2001 414-420
12. F.J. Castro J.I. Esteban A. Juarez et al. Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C J Viral Hepatitis 9 2002 202-207
13. M. Nagaki M. Imose T. Naiki et al. Prospective study on early virologic response to treatment with interferon alpha-2b plus ribavirin in patients with chronic hepatitis C genotype 1b Hepatol Res 33 2005 285-291
14. T.H. Kim K.A. Kim Y.S. Lim et al. Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy Intervirology 48 2005 230-238
15. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C: 2002. Hepatology 2002;36(Suppl.):S3-S20.
16. G.L. Davis J.B. Wong J.G. McHutchison M.P. Manns J. Harvey J. Albrecht Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C Hepatology 38 2003 645-652
17. A. Tsubota Y. Arase T. Someya et al. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load J Med Virol 75 2005 27-34
18. P. Ferenci M.W. Fried M.L. Shiffman et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin J Hepatol 43 2005 425-433
19. T. Berg C. Sarrazin E. Herrmann et al. Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy Hepatology 37 2003 600-609